170 results

  • SOS Stool method brings Xpert TB diagnosis closer to children

    Tuesday 28 January 2020

    Using stool samples to diagnose TB in children with Xpert is now recommended by the WHO. KNCV Tuberculosis Foundation is thrilled with this recommendation. “Our hard work payed off. We […]

  • The story of Issayas

    Tuesday 28 January 2020

    On the outskirts of Addis Ababa in Ethiopia, toddler Issayas lives with his father and mother in a small weathered house with a corrugated iron roof. “Abi”, as he is […]

  • ASCENT announcement: Request for proposal

    Wednesday 22 January 2020

    The ASCENT project announces a Request for Proposals (RFP) for Provision of hosting services for the ASCENT Digital Adherence Platform. Submitted questions and answers about this RFP can be found […]

  • ASCENT procurement announcement: Requests for quotation

    Monday 13 January 2020

    The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming and outgoing interactions with adherence platform. Submitted questions and answers […]

  • Resistant forms of TB: more patient-friendly treatment

    Monday 13 January 2020

    People suffering from resistant forms of tuberculosis (TB) can now be cured by more patient-friendly treatments. The World Health Organization (WHO) recommends the use of these new treatments under certain […]

  • TB Stigma Reduction Symposium

    Sunday 12 January 2020

    INVITATION: Stigma and discrimination are recognized as some of the most commonly identified barriers to fight the Tuberculosis (TB) epidemic. During the TB Stigma Reduction Symposium: “You have to know […]

  • The story of Abdurahim

    Sunday 12 January 2020

    Four-year-old Abdurahim from Kyrgyzstan is so small he looks half that age. He had spinal and intra-thoracic lymph node tuberculosis (TB), a very rare and dangerous form of the disease […]

  • Start of a new era in fight against drug resistant TB

    Thursday 12 December 2019

    WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This puts an ‘end to tears’, for painful daily injections in […]

  • 7th European Advanced Course in Clinical Tuberculosis

    Wednesday 20 November 2019

    The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers with a comprehensive experience in the field of clinical tuberculosis […]

  • 3HP regimen soon to be accessible in Malawi

    Thursday 31 October 2019

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the Union World Conference on Lung Health in India. “For people […]